12 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2024 Popik P, Cyrano E, Piotrowska D, Holuj M, Golebiowska J, Malikowska-Racia N, Potasiewicz A, Nikiforuk A. Effects of ketamine on rat social behavior as analyzed by DeepLabCut and SimBA deep learning algorithms. Frontiers in Pharmacology. 14: 1329424. PMID 38269275 DOI: 10.3389/fphar.2023.1329424  0.509
2023 Malikowska-Racia N, Koniewski M, Golebiowska J, Popik P. Acute but not long-lasting antidepressant-like effect of psilocybin in differential reinforcement of low-rate 72 schedule in rats. Journal of Psychopharmacology (Oxford, England). 37: 1149-1156. PMID 37842884 DOI: 10.1177/02698811231205692  0.527
2023 Szczepańska K, Bojarski AJ, Popik P, Malikowska-Racia N. Novel object recognition test as an alternative approach to assessing the pharmacological profile of sigma-1 receptor ligands. Pharmacological Reports : Pr. PMID 37572216 DOI: 10.1007/s43440-023-00516-x  0.478
2022 Malikowska-Racia N, Golebiowska J, Nikiforuk A, Khoo SY, Popik P. Effects of ketamine optical isomers, fluoxetine and naloxone on timing in differential reinforcement of low-rate response (DRL) 72-s task in rats. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 67: 37-52. PMID 36476352 DOI: 10.1016/j.euroneuro.2022.11.007  0.642
2022 Grychowska K, Olejarz-Maciej A, Blicharz K, Pietruś W, Karcz T, Kurczab R, Koczurkiewicz P, Doroz-Płonka A, Latacz G, Keeri AR, Piska K, Satała G, Pęgiel J, Trybała W, Jastrzębska-Więsek M, ... ... Malikowska-Racia N, et al. Overcoming undesirable hERG affinity by incorporating fluorine atoms: A case of MAO-B inhibitors derived from 1 H-pyrrolo-[3,2-c]quinolines. European Journal of Medicinal Chemistry. 236: 114329. PMID 35397400 DOI: 10.1016/j.ejmech.2022.114329  0.473
2022 Popik P, Hogendorf A, Bugno R, Khoo SY, Zajdel P, Malikowska-Racia N, Nikiforuk A, Golebiowska J. Effects of ketamine optical isomers, psilocybin, psilocin and norpsilocin on time estimation and cognition in rats. Psychopharmacology. PMID 35234983 DOI: 10.1007/s00213-021-06020-5  0.631
2021 Zajdel P, Grychowska K, Mogilski S, Kurczab R, Satała G, Bugno R, Kos T, Gołębiowska J, Malikowska-Racia N, Nikiforuk A, Chaumont-Dubel S, Bantreil X, Pawłowski M, Martinez J, Subra G, et al. Structure-Based Design and Optimization of FPPQ, a Dual-Acting 5-HT and 5-HT Receptor Antagonist with Antipsychotic and Procognitive Properties. Journal of Medicinal Chemistry. PMID 34467765 DOI: 10.1021/acs.jmedchem.1c00224  0.639
2021 Sałaciak K, Malikowska-Racia N, Lustyk K, Siwek A, Głuch-Lutwin M, Kazek G, Popiół J, Sapa J, Marona H, Żelaszczyk D, Pytka K. Synthesis and Evaluation of the Antidepressant-like Properties of HBK-10, a Novel 2-Methoxyphenylpiperazine Derivative Targeting the 5-HT and D Receptors. Pharmaceuticals (Basel, Switzerland). 14. PMID 34451841 DOI: 10.3390/ph14080744  0.339
2021 Malikowska-Racia N, Salat K, Gdula-Argasinska J, Popik P. Sex, Pramipexole and Tiagabine Affect Behavioral and Hormonal Response to Traumatic Stress in a Mouse Model of PTSD. Frontiers in Pharmacology. 12: 691598. PMID 34276379 DOI: 10.3389/fphar.2021.691598  0.475
2019 Malikowska-Racia N, Popik P, Sałat K. Behavioral effects of buspirone in a mouse model of posttraumatic stress disorder. Behavioural Brain Research. 112380. PMID 31765726 DOI: 10.1016/j.bbr.2019.112380  0.543
2019 Malikowska-Racia N, Sałat K, Nowaczyk A, Fijałkowski Ł, Popik P. Dopamine D2/D3 receptor agonists attenuate PTSD-like symptoms in mice exposed to single prolonged stress. Neuropharmacology. 155: 1-9. PMID 31085186 DOI: 10.1016/j.neuropharm.2019.05.012  0.507
2019 Malikowska-Racia N, Popik P, Sałat K. P.517 mGluR2/3 receptor antagonist LY341495 attenuates PTSD symptoms mimicked in a mouse model of single-prolonged stress European Neuropsychopharmacology. 29: S364-S365. DOI: 10.1016/j.euroneuro.2019.09.523  0.474
Show low-probability matches.